Screener
NovoCure NVCR International markets - Total — Net revenues
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: NovoCure’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 6:59 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001645113-26-000062
| Line item | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 | Year ended Year ended December 31, 2025 |
|---|---|---|---|---|---|
| International markets: | |||||
| Germany | 23,341 | 19,074 | 47,845 | 37,792 | 79,407 |
| France | 21,347 | 18,416 | 44,225 | 36,275 | 76,189 |
| Japan | 11,780 | 9,484 | 22,023 | 18,193 | 37,786 |
| Other international markets | 18,205 | 12,979 | 33,884 | 24,916 | 56,898 |
| International markets - Total | 74,673 | 59,953 | 147,977 | 117,176 | 250,280 |
| Greater China (1) | 5,956 | 4,591 | 10,751 | 9,208 | 19,441 |
| Total net revenues | $183,584 | $158,805 | $357,639 | $313,799 | $655,353 |
Item 1. Financial Statements
FAQ
- What is NovoCure's international markets - total — net revenues?
- NovoCure (NVCR) reported international markets - total — net revenues of $74.67M in Q2 2026.
- How has NovoCure's international markets - total — net revenues changed year-over-year?
- NovoCure's international markets - total — net revenues increased by 24.6% year-over-year, from $59.95M to $74.67M.
- What is the long-term trend for NovoCure's international markets - total — net revenues?
- Over 4 years (2021 to 2025), NovoCure's international markets - total — net revenues has grown at a 12.0% compound annual growth rate (CAGR), from $159.16M to $250.28M.
- What does international markets - total — net revenues mean?
- This metric represents the total gross sales generated from the sale of medical devices and associated services within all geographic regions outside of the company's primary domestic market. It serves as a key indicator of the company's global commercial expansion and the adoption rate of its proprietary therapeutic technologies in international healthcare systems. Monitoring this figure helps investors assess the effectiveness of the company's international distribution strategy and its ability to navigate diverse regulatory and reimbursement environments.
Ask your AI about NovoCure's international markets - total — net revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude